IntrinsicIntrinsic
← Scroll for more →

Financial Statements — ONMD

Balance Sheet

(in millions USD)
MetricQ2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024Q2 2024Q1 2024Q4 2023Q3 2023Q2 2023Q1 2023Q4 2022Q3 2022Q2 2022Q1 2022Q4 2021Q3 2021
Cash & Equivalents0.360.230.590.150.120.140.171.930.410.170.050.610.000.010.030.230.010.160.450.53
Accounts Receivable0.660.700.500.580.250.250.210.060.080.250.150.09----------------
Total Current Assets1.311.462.101.452.271.633.624.300.960.660.370.020.000.010.030.230.010.200.540.68
Property, Plant & Equipment0.050.050.060.060.070.100.110.080.090.090.105.00----------------
Total Non-current Assets*0.050.050.060.060.070.100.110.080.090.090.102.8529.9829.7329.03120.13118.66117.36117.32117.30
Total Assets1.361.512.151.512.341.733.734.391.040.750.462.8729.9829.7429.06120.37118.67117.57117.86117.98
Accounts Payable3.473.943.503.855.256.876.046.166.485.884.681.48----------------
Short-term Debt0.700.840.97----2.339.382.31------------------------
Total Current Liabilities4.735.364.835.016.1618.1519.2318.6320.0514.6613.373.082.092.341.981.451.170.570.290.02
Long-term Debt0.130.180.22----2.332.322.312.39----------------------
Total Non-current Liabilities*0.160.230.290.440.020.130.450.030.181.790.5347.558.047.547.147.235.676.118.888.81
Total Liabilities4.885.595.125.456.1818.2819.6818.6620.2316.4513.9150.6310.139.889.128.696.836.689.178.83
Retained Earnings(108.99)(106.82)(104.37)(101.23)(100.49)(103.47)(101.57)(99.20)(97.14)(93.55)(91.44)(12.54)(11.72)(11.72)(11.63)(8.45)(6.61)(6.41)(8.61)(8.15)
Total Stockholder Equity*(3.52)(4.08)(2.96)(3.94)(3.84)(16.55)(15.95)(14.27)(19.19)(15.70)(13.44)(11.62)19.8519.86(8.81)(8.45)(6.61)(6.41)(8.61)(8.14)
← Scroll for more columns →

* Derived from reported values

Income Statement

(in millions USD) (except per-share rows)
MetricQ2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024Q2 2024Q1 2024Q4 2023Q3 2023Q2 2023Q1 2023Q4 2022Q3 2022Q2 2022Q1 2022Q3 2021Q2 2021
Total Revenue0.290.100.890.180.160.140.030.140.230.250.340.330.360.20--0.89--------
Cost of Revenue0.860.480.710.400.400.360.050.230.330.320.340.29----------------
Gross Profit(0.56)(0.38)0.18(0.22)(0.24)(0.22)(0.03)(0.08)(0.10)(0.07)0.000.03----------------
Research & Development0.320.310.460.320.380.350.340.300.380.450.930.41----------------
Selling, General & Admin0.981.482.451.391.181.362.091.871.721.361.381.31----------------
Total Operating Expenses1.702.173.332.011.822.002.642.302.352.032.441.96----------------
Operating Income(2.26)(2.55)(3.14)(2.23)(2.06)(2.22)(2.66)(2.39)(2.45)(2.10)(5.30)(0.92)(0.29)(0.35)(3.38)(0.52)(0.79)(0.61)(0.10)(0.07)
Interest Expense--------------0.010.020.03(0.49)0.50----------------
Pretax Income--(2.45)------(1.90)--------(33.06)(0.73)0.06(0.03)(2.55)(0.05)--------
Tax Provision--------------------(0.19)0.090.060.060.110.11--------
Net Income(2.17)(2.45)(3.14)(0.74)2.98(1.90)(2.37)(2.06)(3.59)(2.11)(32.87)(0.82)(0.09)(0.09)(2.66)(0.15)0.952.201.294.31
Basic EPS(0.04)(0.04)(0.60)(0.01)0.07(0.06)(0.50)(0.07)(0.15)(0.09)(20.70)(28.70)----------------
Diluted EPS(0.04)(0.04)(0.60)(0.01)0.07(0.06)(0.50)(0.07)(0.15)(0.09)(12.70)(28.70)----------------
← Scroll for more columns →

Cash Flow Statement

(in millions USD)
MetricQ2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024Q2 2024Q1 2024Q4 2023Q3 2023Q2 2023Q1 2023Q4 2022Q3 2022Q2 2022Q1 2022Q3 2021Q2 2021
Operating Cash Flow(1.87)(1.54)(1.71)(1.56)(2.28)(1.85)(2.03)(1.90)(1.51)(1.55)(3.99)(0.15)(0.59)(0.05)(0.14)(0.35)(0.15)(0.29)0.36(0.65)
Capital Expenditures0.010.000.010.000.000.010.040.010.000.010.020.03----------------
Free Cash Flow*(1.88)(1.54)(1.72)(1.56)(2.29)(1.86)(2.06)(1.91)(1.51)(1.55)(4.01)(0.18)----------------
Investing Cash Flow0.060.35(0.05)1.11(0.67)1.920.37(2.34)-0.00(0.01)(10.87)11.100.09(0.37)(0.21)(0.88)(1.15)--0.00(117.30)
Financing Cash Flow1.940.842.200.482.93(0.09)(0.10)5.472.041.6814.67(10.95)0.500.400.151.461.15--(0.63)118.76
← Scroll for more columns →

* Derived from reported values